GlaxoSmithKline
Last updated on 2013-11-22T06:52+0300.
About this
image
License:
UNKNOWN
| Key Titles and Phrases | Count | Lang | Last Seen |
|---|---|---|---|
| british rival | 50.00% | EN | 02/02/2007 |
| candidate | 50.00% | EN | 15/11/2005 |
| Names | Lang | Count |
|---|---|---|
| GlaxoSmithKline | EN | 22.94% |
| GlaxoSmithKline | FR | 8.56% |
| GlaxoSmithKline | PT | 5.87% |
| GlaxoSmithKline | ES | 5.26% |
| GlaxoSmithKline | DE | 5.20% |
| GlaxoSmithKline | AF | 5.20% |
| GlaxoSmithKline | PL | 5.20% |
| GlaxoSmithKline | TR | 5.20% |
| GlaxoSmithKline | NN | 5.20% |
| GlaxoSmithKline | RU | 5.20% |
| GlaxoSmithKline | NO | 5.20% |
| GlaxoSmithKline | UK | 5.20% |
| GlaxoSmithKline | HR | 5.20% |
| GlaxoSmithKline | AR | 5.20% |
| Glaxo Smith Kline | EN | 0.98% |
| GLAXOSMITHKLINE | EN | 0.90% |
| Glaxo Smith Kline | FR | 0.90% |
| Glaxo Smith Kline | SV | 0.84% |
| Glaxo-Smith-Kline | DE | 0.53% |
| GlaxoSmithKline | SA | 0.39% |
| Glaxo Smithkline | ES | 0.29% |
| Glaxo Smithkline | EN | 0.29% |
| Glaxo Smith Klein | EN | 0.12% |
| Glaxo SmithKline | EN | 0.10% |
| GLAXOSMITHKLINE | FR | 0.06% |
| Glaxo Smithkline | FR | 0.02% |
| GLAXOSMITHKLINE | SA | 0.02% |
| Pharmakonzern Glaxo Smithkline | DE | 0.00% |
| 葛蘭素史克 | ZH | 0.00% |
| Pharmariesen Glaxo Smith Kline | DE | 0.00% |
| Type | Entity Name | Count |
|---|---|---|
 | Pfizer Inc | 4.75% |
| Inc | 4.75% |
| GlaxoSmithKline Plc | 2.53% |
| Novartis | 2.01% |
| World Health Organization | 1.90% |
| European Union | 1.69% |
| Reuters Group | 1.48% |
 | British | 1.48% |
| Drug Administration | 1.16% |
| Commission | 1.16% |
| Donald Trump | 1.06% |
| AstraZeneca PLC | 1.06% |
| Oxford University | 1.06% |
| Strategy | 0.95% |
| Teva Pharmaceuticals | 0.95% |
| Laura Wood | 0.95% |
| Eli Lilly | 0.95% |
| Bristol Myers Squibb | 0.84% |
| Roche Holding AG | 0.84% |
| Five Forces | 0.84% |
| Table | 0.74% |
| European Commission | 0.74% |
| Saudi | 0.74% |
| Roche Ltd | 0.63% |
| Boris Johnson | 0.63% |
| Wall Street | 0.63% |
| Association | 0.63% |
| Sylvie Briand | 0.53% |
| Massimo Scaccabarozzi | 0.53% |
| Stella Kyriakides | 0.53% |
| Type | Entity Name | Score |
|---|---|---|
| Pfizer Inc | 0.0409 |
| GlaxoSmithKline Plc | 0.0239 |
| Novartis | 0.0202 |
| Massimo Scaccabarozzi | 0.0199 |
| Inc | 0.0147 |
| AstraZeneca PLC | 0.0102 |
| Laura Wood | 0.0096 |
| Teva Pharmaceuticals | 0.009 |
| Eli Lilly | 0.0085 |
| Drug Administration | 0.0083 |
| Bristol Myers Squibb | 0.0083 |
| Roche Holding AG | 0.0082 |
| Five Forces | 0.0082 |
| Strategy | 0.0068 |
| Oxford University | 0.0063 |
| Roche Ltd | 0.0059 |
| Table | 0.0054 |
| Pharmaceuticals Inc | 0.0053 |
| Sylvie Briand | 0.0052 |
| Ludwig Burger | 0.005 |
| Abbott Laboratories | 0.005 |
| Austrian government | 0.0049 |
| Justin Trudeau | 0.0049 |
| Stella Kyriakides | 0.0047 |
| European Centre | 0.0046 |
| European Centre for Disease Prevention and Control | 0.0041 |
| Josephine Mason | 0.0041 |
| CAC 40 | 0.0041 |
| Cancer Research | 0.0041 |
| Product Development | 0.0041 |
Show/hide duplicate news articles.
Show/hide duplicate news articles.
Tools
Sunday, October 25, 2020
2:06:00 PM EAT
Languages 
Select your languages
Explore Relations
Please send any comments or suggestions to 